Reagents and instruments for immunology, cell biology and molecular biology.
 
> Camostat mesilate [59721-29-8]

Camostat mesilate [59721-29-8]

Print Print
Please log in

Cat# 10-2196-50mg

Size : 50mg

Brand : Focus Biomolecules

Request more information
Camostat mesilate [59721-29-8]

Camostat mesilate | Serine protease inhibitor/antiviral/anti-inflammatory

CAS:
59721-29-8
Catalog Number:
10-2196
Activity:
Serine protease inhibitor, antiviral, anti-inflammatory activity
Chemical Name:
4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonic acid salt
Alternate Name:
FOY-305; Foipan
Molecular Weight:
494.52
Molecular Formula:
C20H22N4O5 • CH3SO3H
Solubility:
Soluble in DMSO (up to 50 mg/ml) or Water (up to 50 mg/ml)
Physical Properties:
Off-white solid
Purity:
98% by HPLC
NMR (Conforms)
Storage Temperature:
-20°
Stability:
Stable for 2 years  from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month.
Shipping Code:
RT

Available Options

Size: Quantity 
10 Mg$40.00
50 Mg$125.00
Request Quote / Bulk / Custom Size
Product Inquiry

Camostat mesilate (59721-29-8) is a serine protease inhibitor inhibiting plasmin, kallikrein, thrombin as well as trypsin, which attenuates pancreatic fibrosis.1 Reduces weight gain and improves metabolism in obese rodent models.2 In clinical use (in Japan) for pancreatitis.3 Inhibits influenza virus replication in human tracheal epithelial cells.4 Reduces infection of Calu-3 lung cells by SARS-CoV-2 (responsible for COVID-19) via inhibition of the serine protease TMPRSS2 required for viral spike protein priming.5

References/Citations:

1) Gibo et al. (2005), Camostat mesylate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity; Lab Invest., 85 75
2) Albarazanji et al. (2019), Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.; Am. J. Physiol. Gastrointest. Liver Physiol., 316 G653
3) Ueda et al. (2015), The serine protease inhibitor camostat mesylate attenuates the progression of chronic kidney disease through its antioxidant effects; Nephron, 129 223
4) Yamaya et al. (2015), The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells; Pulm. Pharmacol. Ther., 33 66
5) Hoffmann et al. (2020), SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor; Cell, 181 271

CAS:
59721-29-8
Catalog Number:
10-2196
Activity:
Serine protease inhibitor, antiviral, anti-inflammatory activity
Chemical Name:
4-(2-(2-(Dimethylamino)-2-oxoethoxy)-2-oxoethyl)phenyl 4-guanidinobenzoate methanesulfonic acid salt
Alternate Name:
FOY-305; Foipan
Molecular Weight:
494.52
Molecular Formula:
C20H22N4O5 • CH3SO3H
Solubility:
Soluble in DMSO (up to 50 mg/ml) or Water (up to 50 mg/ml)
Physical Properties:
Off-white solid
Purity:
98% by HPLC
NMR (Conforms)
Storage Temperature:
-20°
Stability:
Stable for 2 years  from date of purchase as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 1 month.
Shipping Code:
RT

Safety Data Sheet:

N/A

Product Data Sheet:

Download Product Data Sheet

Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a restocking/refund fee

Camostat mesilate (59721-29-8) is a serine protease inhibitor inhibiting plasmin, kallikrein, thrombin as well as trypsin, which attenuates pancreatic fibrosis.1 Reduces weight gain and improves metabolism in obese rodent models.2 In clinical use (in Japan) for pancreatitis.3 Inhibits influenza virus replication in human tracheal epithelial cells.4 Reduces infection of Calu-3 lung cells by SARS-CoV-2 (responsible for COVID-19) via inhibition of the serine protease TMPRSS2 required for viral spike protein priming.5

References/Citations:

1) Gibo et al. (2005), Camostat mesylate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity; Lab Invest., 85 75
2) Albarazanji et al. (2019), Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.; Am. J. Physiol. Gastrointest. Liver Physiol., 316 G653
3) Ueda et al. (2015), The serine protease inhibitor camostat mesylate attenuates the progression of chronic kidney disease through its antioxidant effects; Nephron, 129 223
4) Yamaya et al. (2015), The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells; Pulm. Pharmacol. Ther., 33 66
5) Hoffmann et al. (2020), SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor; Cell, 181 271